📈 LLY shares climbed 3% after Eli Lilly became the first drugmaker approved to launch GLP‑1 weight‑loss tablets in China.
- 239
- 80
- 32
- 21
- 14
📈 LLY shares climbed 3% after Eli Lilly became the first drugmaker approved to launch GLP‑1 weight‑loss tablets in China.